Dr. Christiane Hampe, PhD, is the recipient of a 4-year research award from the US-Israel Binational Science Foundation (BSF). Her project, entitled “Depletion of autoreactive-B lymphocytes through anti-idiotypic antibodies coupled to cytotoxins: a new approach for the prevention of Type 1 Diabetes”, focuses on the hypotheses that autoantibody-specific anti-Id can be used as a tool in the development of a new therapy for prevention of T1D. Dr. Hampe is Associate Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition.